mapOur Location
Check on Maps
mapContact Us
This email address is being protected from spambots. You need JavaScript enabled to view it.
 

TEAM ACHIEVEMENTS

(According to their role in previous organizations)

Commercial manufacture :

  1. Oral Polio Vaccine

    Final fill finish from Imported bulk and taken upto WHO pre-qualification stage for UNICEF supplies. Supplied up to 1 Billion doses per annum to UNICEF

  2. Recombinant Hepatitis B vaccine

    Plant Project design, construction and commissioning. Technology Transfer from a foreign partner at 600L scale. Construction and commissioning from green field stage. Indian commercial license and WHO pre-qualification obtained for UNICEF supplies. (Cap 25 MD per annum)

  3. Hib-TT conjugate vaccine

    In house developed technology and scale up to 600L. Successful licensing and WHO prequalification. (Cap. 50 MD per annum)

  4. Diphtheria toxoid vaccine

    Plant Project design, construction and commissioning. In house developed technology and scale up to 1000L. Successful licensing and commercialization. (Cap. 30 MD per annum)

  5. Whole cell pertussis vaccine

    Plant Project design, construction and commissioning In house developed technology and scale up to 1000L. Successful licensing and commercialization. (Cap. 50 MD per annum)

  6. Tetanus toxoid vaccine

    Plant Project design, construction and commissioning In house developed technology and scale up to 1200L. Successful licensing and commercialization. (Cap. 70 MD per annum)

  7. Pentavalent Vaccine (DPT-HepB-Hib)

    In house developed technology and scale up to 100L formulation batch. Successful licensing, commercialization and WHO pre-qualification. Secured order worth 1000 cr for UNICEF supplies.

    First in the world for liquid Penta formulation

  8. Quadruple Vaccine (DPT-HepB)

    In house developed technology and scale up to 100L formulation batch. Successful licensing and commercialization

  9. H1N1 vaccine

    Plant Project design, construction and commissioning in a record time of 10 Months to address Pandemic situation. In house developed technology and scale up. Successful licensing and commercialization. (Cap. 60000 eggs per day)

Research and Development projects :

  1. Development of recombinant Anthrax vaccine Product development for US markets. Taken up to IND stage
  2. Acellular pertussis vaccine Product development and pilot scale studies. Successful Phase 1 CT completed
  3. Pneumococcal vaccine Successful polysaccharide and conjugate development at 30L scale. Taken Into animal studies
  4. Sabin Inactivated Polio Vaccine Basic Product development. Successful Phase1 CT. Company has filed patent